Craig Hendrix
Clinical Pharmacology · Baltimore, MDNPI 1679619498
Payments from drug & device makers
Across 146 payments — averaging $10,551 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$820K
- Viiv Healthcare Company$491K
- Merck$223K
- Takeda Pharmaceuticals U.S.A., Inc.$6K
- Cipla USA Inc.$583
What the payments were for
- Consulting fees$26,08457%
- Travel & lodging$18,66240%
- Food & beverage$1,3943%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 65 | $819,883 |
| Viiv Healthcare Company | 21 | $491,042 |
| Merck | 58 | $223,081 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $5,850 |
| Cipla USA Inc. | 1 | $583 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical pharmacology providers in Marylandto place this figure against a meaningful peer group, so we don't.
Other clinical pharmacology in Baltimore
- Paolo DepetrilloBethesda$209K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.